Agilent Technologies Sees Unusually Large Options Volume (A)

Agilent Technologies Inc (NYSE:A) saw unusually large options trading activity on Friday. Traders acquired 39,650 put options on the company. This is an increase of approximately 1,785% compared to the average volume of 2,103 put options.

In other Agilent Technologies news, CEO Michael R. Mcmullen sold 21,850 shares of the stock in a transaction that occurred on Thursday, January 18th. The shares were sold at an average price of $72.50, for a total transaction of $1,584,125.00. Following the transaction, the chief executive officer now owns 324,687 shares of the company’s stock, valued at $23,539,807.50. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, VP Mark Doak sold 4,154 shares of the stock in a transaction that occurred on Tuesday, December 5th. The stock was sold at an average price of $67.00, for a total transaction of $278,318.00. Following the transaction, the vice president now directly owns 68,270 shares in the company, valued at approximately $4,574,090. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 198,141 shares of company stock worth $13,830,045.

A number of large investors have recently modified their holdings of the stock. Vanguard Group Inc. lifted its position in Agilent Technologies by 3.0% in the 2nd quarter. Vanguard Group Inc. now owns 22,093,669 shares of the medical research company’s stock valued at $1,310,374,000 after purchasing an additional 637,698 shares during the last quarter. Victory Capital Management Inc. lifted its position in Agilent Technologies by 8.2% in the 3rd quarter. Victory Capital Management Inc. now owns 3,330,488 shares of the medical research company’s stock valued at $213,817,000 after purchasing an additional 253,250 shares during the last quarter. Wells Fargo & Company MN lifted its position in Agilent Technologies by 27.6% in the 3rd quarter. Wells Fargo & Company MN now owns 2,184,502 shares of the medical research company’s stock valued at $140,244,000 after purchasing an additional 473,047 shares during the last quarter. Impax Asset Management LTD lifted its position in Agilent Technologies by 14.9% in the 3rd quarter. Impax Asset Management LTD now owns 2,106,322 shares of the medical research company’s stock valued at $135,226,000 after purchasing an additional 272,571 shares during the last quarter. Finally, Legal & General Group Plc lifted its position in Agilent Technologies by 2.9% in the 3rd quarter. Legal & General Group Plc now owns 1,690,240 shares of the medical research company’s stock valued at $108,512,000 after purchasing an additional 46,962 shares during the last quarter.

A number of equities analysts have recently commented on the stock. Morgan Stanley reissued an “overweight” rating on shares of Agilent Technologies in a research note on Tuesday, November 14th. Zacks Investment Research lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Thursday, November 16th. Robert W. Baird reaffirmed a “buy” rating and set a $72.00 price target on shares of Agilent Technologies in a report on Friday, November 24th. ValuEngine lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Finally, Barclays raised their price target on shares of Agilent Technologies from $67.00 to $71.00 and gave the company an “overweight” rating in a report on Tuesday, November 21st. Six investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Agilent Technologies currently has an average rating of “Buy” and an average price target of $69.25.

Agilent Technologies (NYSE:A) opened at $73.07 on Monday. The firm has a market cap of $23,520.00, a price-to-earnings ratio of 34.96, a price-to-earnings-growth ratio of 2.21 and a beta of 1.28. The company has a current ratio of 3.30, a quick ratio of 2.85 and a debt-to-equity ratio of 0.37. Agilent Technologies has a fifty-two week low of $47.05 and a fifty-two week high of $73.21.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Monday, November 20th. The medical research company reported $0.67 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.62 by $0.05. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.95%. The business had revenue of $1.19 billion during the quarter, compared to analyst estimates of $1.17 billion. During the same period in the previous year, the business posted $0.59 EPS. The company’s quarterly revenue was up 7.0% on a year-over-year basis. sell-side analysts predict that Agilent Technologies will post 2.58 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd will be issued a $0.149 dividend. The ex-dividend date is Friday, December 29th. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.13. This represents a $0.60 annualized dividend and a dividend yield of 0.82%. Agilent Technologies’s payout ratio is 28.71%.

WARNING: This report was first posted by American Banking News and is the property of of American Banking News. If you are reading this report on another website, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this report can be viewed at https://www.americanbankingnews.com/2018/01/22/agilent-technologies-sees-unusually-large-options-volume-a.html.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply